person

Monica C.

Country
Italy
Department
U.O. Oncoematologia pediatrica

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
38
Sites with multiple studies

Has run more than one trial at 38 of 199 partner sites.

Specializations

Hematologic Oncology

This investigator specializes in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia, with particular focus on pediatric populations. Their research encompasses innovative therapeutic approaches in blood cancer treatment, specifically targeting genetic mutations associated with leukemia.

  • Acute Lymphoblastic Leukemia
  • Philadelphia Chromosome-Positive Disorders
  • Pediatric Blood Cancers

The investigator's work integrates targeted therapy applications with established chemotherapy protocols.

Rare Disease Research

The investigator has developed expertise in treating Langerhans Cell Histiocytosis, focusing on children and adolescents. Their work addresses various manifestations of this rare condition, from single-system to multi-system involvement.

  • Histiocytic Disorders
  • Pediatric Rare Diseases
  • Multi-System Disease Management

Their research interests extend to developing treatment strategies for complex cases involving multiple organ systems.

Pediatric Medicine

The investigator focuses on pediatric and adolescent therapeutic approaches, specializing in complex disease management. Their expertise encompasses both standard and intensive treatment protocols for young patients.

  • Treatment Protocol Development
  • Long-term Disease Management
  • Risk-Adapted Therapy

Their work emphasizes early intervention strategies and long-term outcome improvement in pediatric populations.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.